| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.00B | +19.5% |
| Cost of Revenue | $2.51B | +12.6% |
| Gross Profit | $4.49B | +23.7% |
| R&D Expense | $996.7M | +16.6% |
| SG&A Expense | $122.7M | +3.0% |
| Operating Income | $2.94B | +30.5% |
| Pre-tax Income | $3.27B | +34.8% |
| Income Tax | $413.0M | +23.4% |
| Net Income | $2.85B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.76B | +42.5% |
| Accounts Receivable | $1.14B | +11.3% |
| Inventory | $1.83B | -5.7% |
| Current Assets | $11.91B | +42.0% |
| Total Assets | $14.04B | +41.2% |
| Current Liabilities | $2.73B | +43.1% |
| Total Liabilities | $4.05B | +48.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.71B | +82.3% |
| Investing Cash Flow | -$2.46B | -257.5% |
| Financing Cash Flow | -$421.8M | -403.7% |
| +36.6% |
| EPS (Basic) | $2.27 | -66.4% |
| EPS (Diluted) | $2.23 | -66.1% |
| Stockholders' Equity |
| $9.99B |
| +38.5% |